Advertisement
Screener

SAREPTA THERAPEUTICS, INC. (SRPT) Financing Receivable, Allowance for Credit Loss, Writeoff

2.8 / 5 stars · 68/120 Roast Me

SAREPTA THERAPEUTICS, INC. Financing Receivable, Allowance for Credit Loss, Writeoff

SAREPTA THERAPEUTICS, INC. (SRPT) reported Financing Receivable, Allowance for Credit Loss, Writeoff of $0 for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-12.

Discontinued › Notes › Receivables › and Others

us-gaap:FinancingReceivableAllowanceForCreditLossesWriteOffs · last filed 2013-11-12

  • SAREPTA THERAPEUTICS, INC. financing receivable, allowance for credit loss, writeoff for the quarter ending 2013-09-30 was $0.00.
  • SAREPTA THERAPEUTICS, INC. financing receivable, allowance for credit loss, writeoff for the quarter ending 2013-06-30 was $0.00.
  • SAREPTA THERAPEUTICS, INC. financing receivable, allowance for credit loss, writeoff for the quarter ending 2013-03-31 was $0.00.
Period endFinancing Receivable, Allowance for Credit Loss, Writeoff 3 monthFinancing Receivable, Allowance for Credit Loss, Writeoff 6 monthFinancing Receivable, Allowance for Credit Loss, Writeoff 9 month
2013-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
$0.00
derived: sum of 2 quarters · filed 2013-11-12
$0.00
10-Q · filed 2013-11-12
2013-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
$0.00
10-Q · filed 2013-08-08
2013-03-31$0.00
10-Q · filed 2013-05-09
2012-09-30$0.00
10-Q · filed 2012-11-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
UroGen Pharma Ltd. (URGN)$2.015B-18.42
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Generate Biomedicines, Inc. (GENB)United States$2.052B
COMPASS Pathways plc (CMPS)$1.812B-4.87
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77